Assessment of IgG avidity against pertussis toxin and filamentous hemagglutinin via an adapted enzyme-linked immunosorbent assay (ELISA) using ammonium thiocyanate

Journal of Immunological Methods

Volumn 387, Issue 1-2, 2013, Pages 36-42

  Almanzar, G ^a   Ottensmeier, B ^a   Liese, J ^a   Prelog, M ^a,b  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Ammonium thiocyanate; Antibody avidity; ELISA; Pertussis; Urea

Indexed keywords

FILAMENTOUS HEMAGGLUTININ; HEMAGGLUTININ; IMMUNOGLOBULIN G; PERTUSSIS TOXIN; THIOCYANIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; BINDING AFFINITY; CHILD; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; INCUBATION TEMPERATURE; INCUBATION TIME; NONHUMAN; PERTUSSIS VACCINATION; PRIORITY JOURNAL; SCHOOL CHILD; VACCINATION;

ADOLESCENT; ADULT; ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODY AFFINITY; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMAGGLUTININS; HUMANS; IMMUNOGLOBULIN G; MALE; PERTUSSIS TOXIN; REPRODUCIBILITY OF RESULTS; TEMPERATURE; THIOCYANATES; VACCINATION;

BORDETELLA PERTUSSIS;

EID: 84871452672     PISSN: 00221759     EISSN: 18727905     Source Type: Journal    
DOI: 10.1016/j.jim.2012.09.008     Document Type: Article

References (31)

1. Berek C., Berger A., Apel M. Maturation of the immune response in germinal centers. Cell 1991, 67:1121.
2. Bobic B., Klun I., Vujanic M., Nikolic A., Ivovic V., Zivkovic T., Djurkovic-Djakovic O. Comparative evaluation of three commercial Toxoplasma-specific IgG antibody avidity tests and significance in different clinical settings. J. Med. Microbiol. 2009, 58:358.
3. de Melker H.E., Versteegh F.G., Conyn-Van Spaendonck M.A., Elvers L.H., Berbers G.A., van Der Zee A., Schellekens J.F. Specificity and sensitivity of high levels of immunoglobulin G antibodies against pertussis toxin in a single serum sample for diagnosis of infection with Bordetella pertussis. J. Clin. Microbiol. 2000, 38:800.
4. Devey M.E., Bleasdale K., Lee S., Rath S. Determination of the functional affinity of IgG1 and IgG4 antibodies to tetanus toxoid by isotype-specific solid-phase assays. J. Immunol. Methods 1988, 106:119.
5. Dorner T., Radbruch A. Antibodies and B cell memory in viral immunity. Immunity 2007, 27:384.
6. Eisen H.N. Determination of antibody affinity for haptens and antigens by means of fluorescence quenching. Methods Med. Res. 1964, 10:115.
7. Foote J., Milstein C. Kinetic maturation of an immune response. Nature 1991, 352:530.
8. French D.L., Laskov R., Scharff M.D. The role of somatic hypermutation in the generation of antibody diversity. Science 1989, 244:1152.
9. Goldblatt D., Vaz A.R., Miller E. Antibody avidity as a surrogate marker of successful priming by Haemophilus influenzae type b conjugate vaccines following infant immunization. J. Infect. Dis. 1998, 177:1112.
10. Hedman K., Seppala I. Recent rubella virus infection indicated by a low avidity of specific IgG. J. Clin. Immunol. 1988, 8:214.
11. Hedman L., Soderlund-Venermo M., Jartti T., Ruuskanen O., Hedman K. Dating of human bocavirus infection with protein-denaturing IgG-avidity assays-secondary immune activations are ubiquitous in immunocompetent adults. J. Clin. Virol. 2010, 48:44.
12. Hendrikx L.H., Berbers G.A., Veenhoven R.H., Sanders E.A., Buisman A.M. IgG responses after booster vaccination with different pertussis vaccines in Dutch children 4years of age: effect of vaccine antigen content. Vaccine 2009, 27:6530.
13. Hofmann J., Lierbt U.G. Significance of avidity and immunoblot analysis for rubella IgM-positive serum samples in pregnant women. J. Virol. Methods 2005, 130:66.
14. Inouye S., Hasegawa A., Matsuno S., Katow S. Changes in antibody avidity after virus infections: detection by an immunosorbent assay in which a mild protein-denaturing agent is employed. J. Clin. Microbiol. 1984, 20:525.
15. Kepler T.B., Perelson A.S. Somatic hypermutation in B cells: an optimal control treatment. J. Theor. Biol. 1993, 164:37.
16. Klein U., Kuppers R., Rajewsky K. Variable region gene analysis of B cell subsets derived from a 4-year-old child: somatically mutated memory B cells accumulate in the peripheral blood already at young age. J. Exp. Med. 1994, 180:1383.
17. Kneitz R.H., Schubert J., Tollmann F., Zens W., Hedman K., Weissbrich B. A new method for determination of varicella-zoster virus immunoglobulin G avidity in serum and cerebrospinal fluid. BMC Infect. Dis. 2004, 4:33.
18. Liese J.G., Rieber N., Malzer T., Ocak M., Johnson D.R., Decker M.D. Reactogenicity of tetanus, diphtheria, 5-component acellular pertussis vaccine administered as a sixth consecutive acellular pertussis vaccine dose to adolescents. Pediatr. Infect. Dis. J. 2010, 29:1067.
19. McDonald J., Gall R., Wiedenbach P., Bass V.D., DeLeon B., Brockus C., Stobert D., Wie S., Prange C.A., Ozog F.J., et al. Immunoassay detection of drugs in racing horses. III. Detection of morphine in equine blood and urine by a one step ELISA assay. Res. Commun. Chem. Pathol. Pharmacol. 1988, 59:259.
20. McHeyzer-Williams M.G., McLean M.J., Lalor P.A., Nossal G.J. Antigen-driven B cell differentiation in vivo. J. Exp. Med. 1993, 178:295.
21. Ozkul A., Demir B., Karaoglu T., Alkan F., Dincer E., Oncel T., Burgu I. Maturation of immunoglobulin G avidity after inactive gE deleted bovine herpesvirus type 1 (BHV-1) marker vaccination. Viral Immunol. 2008, 21:3.
22. Pichichero M.E., Voloshen T., Zajac D., Passador S. Avidity maturation of antibody to Haemophilus influenzae type b (Hib) after immunization with diphtheria-tetanus-acellular pertussis-hib-hepatitis B combined vaccine in infants. J. Infect. Dis. 1999, 180:1390.
23. Pichichero M., Papa T., Blatter M., Mitchell D., Kratz R., Sneed J., Bassily E., Casey J., Gilmet G. Immune memory in children previously vaccinated with an experimental quadrivalent meningococcal polysaccharide diphtheria toxoid conjugate vaccine. Pediatr. Infect. Dis. J. 2006, 25:995.
24. Pullen G.R., Fitzgerald M.G., Hosking C.S. Antibody avidity determination by ELISA using thiocyanate elution. J. Immunol. Methods 1986, 86:83.
25. Ridings J., Nicholson I.C., Goldsworthy W., Haslam R., Roberton D.M., Zola H. Somatic hypermutation of immunoglobulin genes in human neonates. Clin. Exp. Immunol. 1997, 108:366.
26. Ridings J., Dinan L., Williams R., Roberton D., Zola H. Somatic mutation of immunoglobulin V(H)6 genes in human infants. Clin. Exp. Immunol. 1998, 114:33.
27. Rieber N., Graf A., Belohradsky B.H., Hartl D., Urschel S., Riffelmann M., Wirsing von Konig C.H., Liese J. Differences of humoral and cellular immune response to an acellular pertussis booster in adolescents with a whole cell or acellular primary vaccination. Vaccine 2008, 26:6929.
28. Riffelmann M., Thiel K., Schmetz J., Wirsing von Koenig C.H. Performance of commercial enzyme-linked immunosorbent assays for detection of antibodies to Bordetella pertussis. J. Clin. Microbiol. 2010, 48:4459.
29. Schallert N., Pihlgren M., Kovarik J., Roduit C., Tougne C., Bozzotti P., Del Giudice G., Siegrist C.A., Lambert P.H. Generation of adult-like antibody avidity profiles after early-life immunization with protein vaccines. Eur. J. Immunol. 2002, 32:752.
30. Zachou K., Liaskos C., Rigopoulou E., Gabeta S., Papamichalis P., Gatselis N., Georgiadou S., Dalekos G.N. Presence of high avidity anticardiolipin antibodies in patients with autoimmune cholestatic liver diseases. Clin. Immunol. 2006, 119:203.
31. Zlamy M., Würzner R., Holzmann H., Brandstätter A., Jeller V., Zimmerhackl L.B., Prelog M. Antibody dynamics after tick-borne encephalitis and measles-mumps-rubella vaccination in children post early thymectomy. Vaccine 2010, 28:8053.